The Cigna Group Recognized as Top Employer for Commitment To Employee Well-Being by Business Group on Health

 Global health company The Cigna Group (NYSE:CI) has been named among the Business Group on Health’s best employers for its excellence in health and well-being. This is the 16th consecutive year The Cigna Group has received this honor, which recognizes its outstanding…

Read MoreThe Cigna Group Recognized as Top Employer for Commitment To Employee Well-Being by Business Group on Health

Express Scripts Further Advances Transparency and Affordability for Consumers and Clients

 Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (PBM) model. The new solutions and capabilities will increase access to affordable…

Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients

UnitedHealthcare Provides $275,000 to Three North Carolina Nonprofits To Improve Health Outcomes for Children

 UnitedHealthcare Community Plan of North Carolina has announced $275,000 in grant funding to three local organizations supporting children in kinship and foster care across the state. “Caring for the most vulnerable members of our community starts with meeting their most…

Read MoreUnitedHealthcare Provides $275,000 to Three North Carolina Nonprofits To Improve Health Outcomes for Children

CVS Health reports first quarter results, completes acquisitions of Signify Health and Oak Street Health

 CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2023. Key financial data   First quarter highlights Note: Financial information for the three months ended March 31, 2022 throughout this press release has been revised…

Read MoreCVS Health reports first quarter results, completes acquisitions of Signify Health and Oak Street Health

Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that it has signed a distribution and collaboration agreement with Adalvo for exclusive Sandoz rights to commercialize six products in the US across key therapeutic areas, including antifungal/antibiotic, oncology…

Read MoreSandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion and recommended granting a marketing authorization for Cosentyx® (secukinumab) in adults with active moderate to severe hidradenitis suppurativa…

Read MoreNovartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa